Ventas's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 13.93.
Ventas's Days Inventory for the
three
months ended in Mar. 2026 was 0.
Ventas's Days Payable for the
three
months ended in Mar. 2026 was 112.9.
Therefore, Ventas's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was -98.97.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Ventas Cash Conversion Cycle Related Terms
Ventas Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Ventas's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VTR vs OHI, DOC, AHR: Cash Conversion Cycle Comparison
For the REIT - Healthcare Facilities subindustry, Ventas's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ventas Cash Conversion Cycle vs REITs Industry
For the REITs industry and Real Estate sector, Ventas's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Ventas's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Ventas's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ventas (VTR) has a Cash Conversion Cycle of -98.97 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ventas and its competitors.
Is Ventas' Cash Conversion Cycle too high?
Ventas' current Cash Conversion Cycle is -98.97. Overall, Ventas has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ventas' Cash Conversion Cycle compare to OHI and DOC?
Ventas' Cash Conversion Cycle of -98.97 can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a REITs company?
A good Cash Conversion Cycle depends on the REITs industry context. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Ventas and its competitors. Ventas's current Cash Conversion Cycle is -98.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ventas stock overvalued right now?
Based on GuruFocus' analysis, Ventas (VTR) is currently considered Modestly Overvalued. The stock's GF Value™ is $69.98, compared to a current price of $89.40 — trading 27.8% above its estimated fair value. The current Cash Conversion Cycle is -98.97. Ventas' overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Ventas (VTR), the current Cash Conversion Cycle is -98.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ventas (VTR) Overvalued in 2026?
Based on GuruFocus' analysis, Ventas stock appears to be overvalued.
The current stock price of $89.40 is trading 27.8% above its estimated GF Value™ of $69.98.
GuruFocus considers Ventas to be Modestly Overvalued.
Key valuation signals for VTR:
Cash Conversion Cycle: -98.97
GF Value™: $69.98 vs. price of $89.40 (27.8% above fair value)
No single metric tells the full story. See the VTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
79GF Score
Get the complete analysis for VTR
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTR has been successfully added to your 
